New Research Validates Clinical Importance of Leukemia Stem Cells and Paves the Way for Personalized Treatment
University Health Network (UHN)Research published today focuses on patients and shows that acute myeloid leukemia (AML) contains rare cells with stem cell properties, called leukemia stem cells (LSC), that are better at predicting clinical outcome than the majority of AML cells, showing for the first time that LSCs are significant not just in experimental models but also in patients.